• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人错配修复蛋白对顺铂-DNA加合物的选择性识别。

Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins.

作者信息

Yamada M, O'Regan E, Brown R, Karran P

机构信息

Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hertfordshire EN6 3LD, UK.

出版信息

Nucleic Acids Res. 1997 Feb 1;25(3):491-6. doi: 10.1093/nar/25.3.491.

DOI:10.1093/nar/25.3.491
PMID:9016586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC146450/
Abstract

The antitumor agent cis-diamminedichloroplatinum(II) (cisplatin) introduces cytotoxic DNA damage predominantly in the form of intrastrand crosslinks between adjacent purines. Binding assays using a series of duplex oligonucleotides containing a single 1,2 diguanyl intrastrand crosslink indicate that human cell extracts contain factors that preferentially recognise this type of damage when the complementary strand contains T opposite the 3', and C opposite the 5'guanine in the crosslink. Under the conditions of the band-shift assay used, little binding is observed if the positions of the T and C are reversed in the complementary strand. Similarly, duplexes containing CC or TT opposite the crosslink are recognised relatively poorly. The binding activity is absent from extracts of the colorectal carcinoma cell lines LoVo and DLD-1 in which the hMutSalpha mismatch recognition complex is inactivated by mutation. Extensively purified human hMutSalpha exhibits the same substrate preference and binds to the mismatched platinated DNA at least as well as to an identical unplatinated duplex containing a single G.T mismatch. It is likely, therefore, that human mismatch repair may be triggered by 1,2 diguanyl intrastrand crosslinks that have undergone replicative bypass.

摘要

抗肿瘤药物顺 - 二氯二氨合铂(II)(顺铂)主要以相邻嘌呤之间的链内交联形式引入细胞毒性DNA损伤。使用一系列含有单个1,2 - 二鸟嘌呤链内交联的双链寡核苷酸进行的结合试验表明,当互补链在交联处3'端相对位置含有T,5'端鸟嘌呤相对位置含有C时,人细胞提取物中含有优先识别这种类型损伤的因子。在所使用的凝胶迁移试验条件下,如果互补链中T和C的位置颠倒,则观察到的结合很少。同样,在交联相对位置含有CC或TT的双链体被识别的程度相对较差。在结直肠癌细胞系LoVo和DLD - 1的提取物中不存在结合活性,在这些细胞系中hMutSα错配识别复合物因突变而失活。经过广泛纯化的人hMutSα表现出相同的底物偏好,并且与错配的铂化DNA结合的能力至少与与含有单个G.T错配的相同未铂化双链体一样好。因此,人错配修复很可能由经历复制性绕过的1,2 - 二鸟嘌呤链内交联触发。

相似文献

1
Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins.人错配修复蛋白对顺铂-DNA加合物的选择性识别。
Nucleic Acids Res. 1997 Feb 1;25(3):491-6. doi: 10.1093/nar/25.3.491.
2
Binding discrimination of MutS to a set of lesions and compound lesions (base damage and mismatch) reveals its potential role as a cisplatin-damaged DNA sensing protein.MutS 对一组损伤和复合损伤(碱基损伤和错配)的结合区分揭示了其作为顺铂损伤 DNA 传感蛋白的潜在作用。
J Biol Chem. 2003 Jun 6;278(23):21267-75. doi: 10.1074/jbc.M301390200. Epub 2003 Mar 24.
3
Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts.顺铂-DNA加合物配对与错配的人核苷酸切除修复差异
Nucleic Acids Res. 1997 Feb 1;25(3):480-91. doi: 10.1093/nar/25.3.480.
4
Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.人类MutSα可识别含有O6-甲基鸟嘌呤、O4-甲基胸腺嘧啶或顺铂-d(GpG)加合物的受损DNA碱基对。
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6443-7. doi: 10.1073/pnas.93.13.6443.
5
Binding of MutS mismatch repair protein to DNA containing UV photoproducts, "mismatched" opposite Watson--Crick and novel nucleotides, in different DNA sequence contexts.MutS错配修复蛋白与含有紫外线光产物的DNA的结合,这些光产物在不同的DNA序列背景下与沃森-克里克核苷酸和新核苷酸“错配”相对。
DNA Repair (Amst). 2005 Aug 15;4(9):983-93. doi: 10.1016/j.dnarep.2005.04.018.
6
MutS recognition of exocyclic DNA adducts that are endogenous products of lipid oxidation.MutS对脂质氧化内源性产物——环外DNA加合物的识别。
J Biol Chem. 1999 Sep 17;274(38):27112-8. doi: 10.1074/jbc.274.38.27112.
7
Interaction studies of muts and mutl with DNA containing the major cisplatin lesion and its mismatched counterpart under equilibrium and nonequilibrium conditions.在平衡和非平衡条件下,对muts和mutl与含有主要顺铂损伤及其错配对应物的DNA进行相互作用研究。
Biopolymers. 2013 Sep;99(9):636-47. doi: 10.1002/bip.22232.
8
MutS inhibits RecA-mediated strand exchange with platinated DNA substrates.MutS抑制RecA介导的与铂化DNA底物的链交换。
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14174-9. doi: 10.1073/pnas.0406104101. Epub 2004 Sep 16.
9
Modulation of MutS ATP-dependent functional activities by DNA containing a cisplatin compound lesion (base damage and mismatch).含顺铂复合损伤(碱基损伤和错配)的DNA对MutS ATP依赖性功能活性的调节
J Mol Biol. 2007 May 25;369(1):27-40. doi: 10.1016/j.jmb.2007.02.048. Epub 2007 Feb 22.
10
Separation of mutation avoidance and antirecombination functions in an Escherichia coli mutS mutant.大肠杆菌mutS突变体中突变避免功能与抗重组功能的分离
Nucleic Acids Res. 2005 Feb 24;33(4):1193-200. doi: 10.1093/nar/gki263. Print 2005.

引用本文的文献

1
Platinum chemotherapeutic-induced oxidative stress affects the transcriptional response of DNA repair genes in murine mesenchymal stem cells.铂类化疗药物诱导的氧化应激影响小鼠间充质干细胞中DNA修复基因的转录反应。
Am J Stem Cells. 2025 Jun 15;14(2):34-52. doi: 10.62347/TICZ7344. eCollection 2025.
2
Replication-Independent ICL Repair: From Chemotherapy to Cell Homeostasis.复制独立型 ICL 修复:从化疗到细胞稳态。
J Mol Biol. 2024 Jul 1;436(13):168618. doi: 10.1016/j.jmb.2024.168618. Epub 2024 May 18.
3
Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives.重新审视临床批准的铂类衍生物的抗癌毒性。
Int J Mol Sci. 2022 Dec 6;23(23):15410. doi: 10.3390/ijms232315410.
4
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors.睾丸生殖细胞肿瘤中顺铂敏感性和耐药性的机制
Cancer Drug Resist. 2019;2(3):580-594. doi: 10.20517/cdr.2019.19. Epub 2019 Sep 19.
5
Holding All the Cards-How Fanconi Anemia Proteins Deal with Replication Stress and Preserve Genomic Stability.手握所有牌——范可尼贫血蛋白如何应对复制压力并维持基因组稳定性。
Genes (Basel). 2019 Feb 22;10(2):170. doi: 10.3390/genes10020170.
6
Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective.从当前免疫原性和单克隆抗体角度对顺铂和奥沙利铂的综述
World J Oncol. 2014 Jun;5(3):97-108. doi: 10.14740/wjon830w. Epub 2014 Jun 25.
7
Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity.高迁移率族蛋白4修复睾丸生殖细胞肿瘤中铂-DNA损伤的屏蔽作用导致顺铂超敏反应。
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):950-955. doi: 10.1073/pnas.1615327114. Epub 2017 Jan 17.
8
DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy.DNA聚合酶β种系变体赋予细胞对顺铂治疗的反应。
Mol Cancer Res. 2017 Mar;15(3):269-280. doi: 10.1158/1541-7786.MCR-16-0227-T. Epub 2017 Jan 10.
9
Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.错配修复蛋白在顺铂链间交联处理中的作用。
DNA Repair (Amst). 2015 Nov;35:126-36. doi: 10.1016/j.dnarep.2015.10.003. Epub 2015 Oct 23.
10
Review of Cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments.顺铂和奥沙利铂在当前免疫原性及单克隆抗体治疗中的综述。
Oncol Rev. 2014 Sep 23;8(2):256. doi: 10.4081/oncol.2014.256.

本文引用的文献

1
Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts.顺铂-DNA加合物配对与错配的人核苷酸切除修复差异
Nucleic Acids Res. 1997 Feb 1;25(3):480-91. doi: 10.1093/nar/25.3.480.
2
Fork-like DNA templates support bypass replication of lesions that block DNA synthesis on single-stranded templates.叉状DNA模板支持绕过在单链模板上阻断DNA合成的损伤进行复制。
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13766-9. doi: 10.1073/pnas.93.24.13766.
3
Mismatch repair in replication fidelity, genetic recombination, and cancer biology.复制保真度、基因重组及癌症生物学中的错配修复
Annu Rev Biochem. 1996;65:101-33. doi: 10.1146/annurev.bi.65.070196.000533.
4
The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin.错配修复蛋白hMSH2能选择性地与抗癌药物顺铂的DNA加合物结合。
Chem Biol. 1996 Jul;3(7):579-89. doi: 10.1016/s1074-5521(96)90149-0.
5
hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA.hMutSβ是hMSH2和hMSH3的异源二聚体,可与DNA中的插入/缺失环结合。
Curr Biol. 1996 Sep 1;6(9):1181-4. doi: 10.1016/s0960-9822(02)70685-4.
6
Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line.顺铂和阿霉素耐药与一种卵巢肿瘤细胞系中的MutLα及错配修复缺陷相关。
J Biol Chem. 1996 Aug 16;271(33):19645-8. doi: 10.1074/jbc.271.33.19645.
7
Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.人类MutSα可识别含有O6-甲基鸟嘌呤、O4-甲基胸腺嘧啶或顺铂-d(GpG)加合物的受损DNA碱基对。
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6443-7. doi: 10.1073/pnas.93.13.6443.
8
Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine.复制后DNA错配修复在硫鸟嘌呤细胞毒性作用中的作用。
Science. 1996 Aug 23;273(5278):1109-11. doi: 10.1126/science.273.5278.1109.
9
Loss of DNA mismatch repair in acquired resistance to cisplatin.顺铂获得性耐药中DNA错配修复的缺失
Cancer Res. 1996 Jul 1;56(13):3087-90.
10
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.耐药肿瘤细胞中的微卫星不稳定性、细胞凋亡及p53功能丧失
Cancer Res. 1996 Mar 15;56(6):1374-81.